BRANSONPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BRANSONPHARMA
Largest movements
- Tangible fixed assets -€64,453
down €64,453 (-7.2%), from €897,331 to €832,879
of which Land and buildings: -€55,113
- Stocks and contracts +€13,446
up €13,446 (+11.9%), from €112,759 to €126,204
- Receivables within one year +€12,666
up €12,666 (+23.8%), from €53,260 to €65,927
of which Trade receivables: +€12,991
- Debts after one year -€68,272
down €68,272 (-10.5%), from €652,931 to €584,659
- Reserves +€30,290
up €30,290 (+32.6%), from €92,840 to €123,130
- Other debts -€11,630
down €11,630 (-6.9%), from €167,543 to €155,914
- Gross operating margin +€23,332
up €23,332 (+19.2%), from €121,230 to €144,562
- Depreciation -€13,376
down €13,376 (-17.0%), from €78,845 to €65,469
- Taxes +€9,749
up €9,749 (+441.7%), from €2,207 to €11,956
- Other operating charges +€1,766
up €1,766 (+33.7%), from €5,233 to €6,999
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,135,645 | €1,093,429 | -€42,216 | -3.7% |
| Fixed assets | 21/28 | €897,331 | €832,879 | -€64,453 | -7.2% |
| Tangible fixed assets | 22/27 | €897,331 | €832,879 | -€64,453 | -7.2% |
| Land and buildings | 22 | €871,537 | €816,425 | -€55,113 | -6.3% |
| Plant, machinery and equipment | 23 | €24,308 | €14,829 | -€9,479 | -39.0% |
| Furniture and vehicles | 24 | €1,486 | €1,625 | +€139 | +9.3% |
| Current assets | 29/58 | €238,314 | €260,551 | +€22,237 | +9.3% |
| Stocks and contracts in progress | 3 | €112,759 | €126,204 | +€13,446 | +11.9% |
| Stocks | 30/36 | €112,759 | €126,204 | +€13,446 | +11.9% |
| Amounts receivable within one year | 40/41 | €53,260 | €65,927 | +€12,666 | +23.8% |
| Trade receivables | 40 | €47,060 | €60,051 | +€12,991 | +27.6% |
| Other amounts receivable | 41 | €6,200 | €5,875 | -€325 | -5.2% |
| Cash at bank and in hand | 54/58 | €68,280 | €67,230 | -€1,050 | -1.5% |
| Deferred charges and accrued income | 490/1 | €4,014 | €1,189 | -€2,825 | -70.4% |
| Total equity and liabilities | 10/49 | €1,135,645 | €1,093,429 | -€42,216 | -3.7% |
| Equity | 10/15 | €144,174 | €174,472 | +€30,298 | +21.0% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €92,840 | €123,130 | +€30,290 | +32.6% |
| Distributable reserves | 133 | €92,840 | €123,130 | +€30,290 | +32.6% |
| Profit (loss) carried forward | 14 | €38,934 | €38,942 | +€8 | 0.0% |
| Amounts payable | 17/49 | €991,471 | €918,957 | -€72,514 | -7.3% |
| Amounts payable after more than one year | 17 | €652,931 | €584,659 | -€68,272 | -10.5% |
| Financial debts | 170/4 | €652,931 | €584,659 | -€68,272 | -10.5% |
| Amounts payable within one year | 42/48 | €338,540 | €334,298 | -€4,242 | -1.3% |
| Current portion of amounts payable after more than one year | 42 | €116,766 | €118,272 | +€1,506 | +1.3% |
| Trade debts | 44 | €48,430 | €48,808 | +€378 | +0.8% |
| Suppliers | 440/4 | €48,430 | €48,808 | +€378 | +0.8% |
| Taxes, remuneration and social security | 45 | €5,801 | €11,305 | +€5,504 | +94.9% |
| Taxes | 450/3 | €5,801 | €11,305 | +€5,504 | +94.9% |
| Other amounts payable | 47/48 | €167,543 | €155,914 | -€11,630 | -6.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €78,845 | €65,469 | -€13,376 | -17.0% |
| Other operating charges | 640/8 | €5,233 | €6,999 | +€1,766 | +33.7% |
| Gross operating margin | 9900 | €121,230 | €144,562 | +€23,332 | +19.2% |
| Operating profit (loss) | 9901 | €37,152 | €72,094 | +€34,942 | +94.1% |
| Financial income | 75/76B | €529 | €1,334 | +€805 | +152.0% |
| Recurring financial income | 75 | €529 | €1,334 | +€805 | +152.0% |
| Financial charges | 65/66B | €30,985 | €31,174 | +€189 | +0.6% |
| Recurring financial charges | 65 | €30,985 | €31,174 | +€189 | +0.6% |
| Profit (loss) for the period before taxes | 9903 | €6,696 | €42,254 | +€35,558 | +531.1% |
| Income taxes | 67/77 | €2,207 | €11,956 | +€9,749 | +441.7% |
| Profit (loss) for the period | 9904 | €4,488 | €30,298 | +€25,809 | +575.0% |
| Profit (loss) for the period to be appropriated | 9905 | €4,488 | €30,298 | +€25,809 | +575.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.